AIM IMMUNOTECH INC.
Ocala
About AIM IMMUNOTECH INC.
AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders. As a result, they have developed strong laboratory and clinical data in relation to the development of nucleic acids and natural interferon to enhance the natural antiviral defence system of the human body and aid in the development of therapeutic products designed to treat cancer and chronic diseases. The company is committed to finding co-development partners with the capital and expertise to commercialize the many potential therapeutic aspects of Ampligen.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $26.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nysemkt:AIM
- Website: aimimmuno.com
- Phone: (352)-448-7797
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/aim-immunotech-inc-52478 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.